Puretech Health plc (PRTC) Ordinary 1p

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
PureTech Health CEO Bharatt Chowrira steps down
16 July 2025 07:44
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health said on Wednesday that chief executive officer Bharatt Chowrira has stepped down with immediate effect.
-
PureTech financials improve in a year of clinical, regulatory milestones
30 April 2025 10:35
(Sharecast News) - PureTech Health impressed the market with its annual results for 2024, as the company maintained a strong cash position while hitting a number of key clinical and regulatory milestones...
-
London close: Stocks weaker ahead of key central bank decisions
16 December 2024 15:35
(Sharecast News) - London stocks ended lower on Monday as investors adopted a cautious stance ahead of a week filled with major central bank policy decisions.
-
PureTech hails "exciting" results from lung disease trial
16 December 2024 09:30
(Sharecast News) - Clinical-stage biotech group Puretech Health has announced promising results from the trial of its lung disease treatment deupirfenidone, which the lead investigator hailed as...
-
London close: Stocks give up gains to finish in the red
21 October 2024 15:48
(Sharecast News) - London stocks ended lower on Monday, after the People's Bank of China made bigger-than-expected cuts to loan prime rates, while UK house price growth stagnated.
-
PureTech's Seaport closes $225m series B round
21 October 2024 12:45
(Sharecast News) - PureTech Health announced on Monday that Seaport Therapeutics, a company it founded, has closed an oversubscribed $225m series B financing round.
-
London close: Stocks rise as US PCE inflation slows
27 September 2024 16:58
(Sharecast News) - London stocks closed higher on Friday as investors digested a slowdown in the Federal Reserve's preferred inflation measure.
-
PureTech receives $29m royalty from Karuna schizophrenia treatment
27 September 2024 07:17
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health has announced that the schizophrenia treatment it developed, which was later sold to Bristol Myers Squibb, has been approved by US...
-
PureTech Health launches $100m tender offer
20 May 2024 10:13
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health launched a proposed $100m tender offer on Monday, aiming to repurchase shares at a fixed price of 250p each, or £25.00 per American...
-
Puretech Health operating losses narrow in 'landmark year'
25 April 2024 10:07
(Sharecast News) - Biotechnology company Puretech Health said on Thursday that 2023 had been "a landmark year" for the group, making "strong strategic and clinical progress".
-
PureTech founder steps down as CEO to lead SeaPort spin-off
9 April 2024 07:48
(Sharecast News) - Clinical-stage biotherapeutics group PureTech has announced that its founding chief executive is to step down to lead SeaPort Therapeutics, a PureTech company she founded that has just...
-
Puretech Health proposes $100m capital return
19 March 2024 09:46
(Sharecast News) - Biotherapeutics company PureTech Health has proposed a capital return of $100.0m to its shareholders by way of a tender offer.
Company announcements Announcements
-
PRTC’s Seaport Begins Phase 2b Study in MDD
17 July 2025 12:05
PureTech Health
-
PureTech Announces Leadership Transition
16 July 2025 07:00
PureTech Health
-
Directorate Change
8 July 2025 17:45
PureTech Health
-
PDMR Notification RSU Vesting
4 July 2025 17:30
PureTech Health
-
PDMR Notification RSU Vesting
4 July 2025 17:30
PureTech Health
-
PDMR Notification
4 July 2025 17:30
PureTech Health
-
Total Voting Rights
1 July 2025 07:00
PureTech Health
-
PRTC'S Vor Announces RemeGen License & $175M PIPE
26 June 2025 07:00
PureTech Health
-
Result of AGM
16 June 2025 17:27
PureTech Health
-
Holding(s) in Company
29 May 2025 17:30
PureTech Health
-
PRTC to Present at Jefferies Healthcare Conference
22 May 2025 12:00
PureTech Health
-
PRTC: IPF Data Support Lung Function Stabilization
21 May 2025 07:00
PureTech Health
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.